Kaposi's sarcoma (KS)-associated herpes virus and its role in KS

Infectious Agents and Disease

Volumn 5, Issue 4, 1996, Pages 215-222

  Chang, Yuan ^a   Moore, Patrick S ^b  

^a The New York Presbyterian Hospital   (United States)

^b Columbia University ^*  (United States)

Author keywords

Herpesvirus 8; Kaposi's sarcoma; Kaposi's sarcoma associated herpesvirushuman

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DNA SEQUENCE; HERPES VIRUS; HERPES VIRUS SAIMIRI; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOMA; ONCOVIRINAE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; VIRUS ISOLATION; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; SARCOMA, KAPOSI;

EID: 0029839227     PISSN: 10562044     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Adams V, Kempf W, Schmid M, Müller B, BrinerJ, Burg G. Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet 1995;346;1715.
2. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type I Tat protein. Proc Natl Acad Sci USA !995;92;4838-42.
3. Albrecht J-C Nicholas J, Biller D, et al. Primary structure of the Herpesvirus saimiri genome. J Virol 1992;66:5047-58.
4. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpeslike sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995:268-582-3.
5. Archibald CP, Schechter MT, Craib KJ, et al. Risk factors for Kaposi's sarcoma in the Vancouver LymphadenopathyAIDS Study. J AIDS !990;3(suppl):S 18-23.
6. Archibald CP, Schechter MT, Le TN, Craib KJP, Montaner JSG, O'Shaughnessy MV. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology !992;3:203-9.
7. Armenian HK, Hoover DR, Rubb S, et al. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am ] Epidemiol 1993;138:256-65.
8. Baer R, Bankier AT, Biggin PL, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984:310:207-11.
9. Beral V, Bull D, Darby S, et al. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992:339:632-5.
10. Beral V, Bull D, Jaffe H, et al. Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from United States or Africa? Br Meet J 1991:302:624-5.
11. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990:335:123-8.
12. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpes virus (KSHV) infects endothelial and spindle cells. Nature Med 1995:1:1274-8.
13. Boshoff C, Talbot S, Kennedy M, et al. New herpesvirus and immunosuppressed skin cancer. Lancet 1996:347:338-9.
14. Boshoff C, Whitby D, Hatziionnou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995:345:1043-44.
15. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences are present in AIDS-related body cavity based lymphomas. N EnglJ Med 1995:332:1186-91.
16. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two AIDS-related lymphoma cell lines containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995:86:2708-14.
17. Cesarman E, Nador RG, Bai F, Russo J, Moore PS, Chang Y, Knowles DM. KSHV/HHV8 contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. (Submitted for publication).
18. Chang Y, Cesarman E, Pessin MS. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;265:1865-9.
19. Chang Y, Ziegler JL, Wabinga H, et al. Kaposi's sarcomaassociated herpesvirus DNA sequences are present in African endemic and AIDS-associated Kaposi's sarcoma. Arch Int Med 1996;156:202-4.
20. DiGiovanna JJ, Safai B. Kaposi's sarcoma: retrospective study of 90 cases with particular emphasis on familial occurrence, ethnic background, and prevalence of other diseases. Am J Med 1981;7l:779-83.
21. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993;73:499-511.
22. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA in patients with Mediterranean Kaposi's sarcoma. Lancet 1995;345:761-2.
23. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Stahl F. tat protein of H1V-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;344:84-6.
24. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 1994;371:674-80.
25. Frizzera G. Castleman's disease. More questions than answers. Hum Pathol 1985; 16:202-5.
26. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia (in press).
27. Giraldo G, Beth E, Buonaguro FM. Kaposi's sarcoma: a natural model of interrelationships between viruses, immunologie responses, genetics and oncogenesis. Antibiot Chemother 1984;32:1-11.
28. Giraldo G, Kourilsky FM, Henle W, et al. Antibody patterns to herpesviruses in Kaposi's sarcoma: serological association of European Kaposi's sarcoma with cytomegalovirus. Int J Cancer 1975; 15:839-48.
29. Hauser AD, Sträuchen JA, Burstein DA, Jiminez R, Moore PS. Chang Y. Kaposi's sarcoma, Kaposi's sarcomaassociated herpesvirus, and body cavity-based malignant lymphoma in an HIV-negative man. (Submitted for publication).
30. Herbst H, Steinbrecher E, Niedobitek G, et al. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992;80:484-l.
31. Herndier BG, Werner A, Arnstein P, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994;8:575-81.
32. Holmberg S, Buchbinder S, Conley L, et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the human immunodeficiency virus. Am J Epidemiol 1995;141:39504.
33. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988;318:73341.
34. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994;77:791-3.
35. Knowles DM, Inghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of Epstein-Barr virus. Blood 1989:73:792-9.
36. Lebbé C, de Crémoux P, Rybojad M, Costa da Cunha C, Morel P, Calvo F. Kaposi's sarcoma and new herpesvirus. Lancet 1995:345:1180.
37. Levy JA. A new human herpesvirus: KSHV or HHV8? Lancet 1995:346:786.
38. Lin J-C, Lin S-C, Mar E-C, et al. Is Kaposi's sarcomaassociated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet 1995;346;1601-2.
39. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995;375:64-8.
40. Lunardi-Iskandar Y, Gill P, Lam VH, et al. Isolation and characterization of an immortal neoplastic cell line (KS Y-l) from AIDS-associated Kaposi's sarcoma. J Null Cancer Inst 1995;87:974-8I.
41. Meinl E, Hohfeld R, Wekerle H, Fleckenstein B. Immortalization of human T cells by Herpesvirus saimiri. Immunol Today 1995;16:55-8.
42. Miles SA. Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol I994;6:497-502.
43. Miles SA, Martinez MO, Rezai A, et al. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 1992:255:1432.
44. Miller G. Rigsby M, Heston L, et al. Antibodies to butyrate inducible antigens of Kaposi's sarcoma-associated herpesvirus in HIV-1 infected patients. N Engl J Med (in press).
45. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma lesions from persons with and without HIV infection. N Engl J Med 1995;332:1181-5.
46. Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus-like agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.
47. Moore PS, Kingsley L, Holmberg SD, et al. KSHV infection prior to onset of Kaposi's sarcoma. AIDS 1996:10:175-80.
48. Nador RG, Cesarman E, Knowles DM, Said JW. Herpeslike DNA sequences in a body cavity-based lymphoma in an HIV-negative patient. N Engl J Med 1995:333:943.
49. Nicholas J, Cameron KR, Honess RW. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 1992:355:362-5.
50. Nickoloff BJ, Huang YQ, Li JJ, Friedman-Kien AE. Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet 1992:339:548-9.
51. Oettle AG, ed. Geographic and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Basel: Karger, 1962:330-63. (Ackerman LV, Murray JF, ed: Symposium on Kaposi's sarcoma: Unio Internationalis Contra Cancrum; vol 18.)
52. Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G. Cyclins Dl and D2 are differentially expressed in human B-lymphoid cell lines. Oncogene 1993:8:1049-54.
53. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferation of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8.
54. Pines J. Cyclins and cyclin-dependent kinases: themes and variations. Adv Cancer Res 1995;66:181-212.
55. Rabkin CS, Bedi G, Musaba E, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1995:1:257-60.
56. Rady PL, Yen A, Rollefson JL, Orengo 1, Bruce S, Hughes TK, Tyring SK. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995 ;345:1339-40.
57. Rangan SR, Martin LN, Enright FM, Abee CR. Herpesvirus saimiri-mduced lymphoproliferative disease in howler monkeys. J Null Cancer Inst 1977:59:165-71.
58. 57a. Renne R, Zhang W, Herndier B, McGrath M, Abbey N, Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med 1996:2:342-6.
59. Roizman B. New viral footprints in Kaposi's sarcoma. N EnglJ Med 1995:332:1227-8.
60. Roth WK, Werner S, Risau W. Remberger K, Hofschneider PH. Cultured, AlDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro. IntJ Cancer 1988 ;42:767-73.
61. Samaniego F, Markham PD, Gallo RC, Ensoli B. Inflammatory cytokines induce AlDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunal 1995:154:3582-92.
62. Schalling M, Ekman M, Kaaya EE, Linde A, Bieberfeld P. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995:1:707-8.
63. Schulz TF, Weiss RA. Kaposi's sarcoma: a finger on the culprit. Nature 1995;373:17-8.
64. Sinclair AJ, Palmero i, Peters G, Farrell PJ. EBNA-2 and EBNA-LP cooperate to cause GO to G l transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 1994;13:332l-8.
65. Soulier J, Grollet L, Oskenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
66. Strathdee SA, Veugelers PJ, Moore PS. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS 1996;10(Suppl):551-7.
67. Su 1-J, Hsu Y-S, Chang Y-C, Wang I-W. Herpesvirus-like DNA sequence in Kaposi's sarcoma from AIDS and nonAIDS patients in Taiwan. Lancet 1995:345:722-3.
68. 66a. Talbot SJ, Boshoff C, Zarkowska T, et al. Functional inactivation of the retinoblastoma protein by KSHV. (Submitted for publication).
69. Tappero JW, Conant MA. Wolfe SF, Berger TG. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993:28:371-95.
70. Telford EA, Watson MS, Aird HC, Perry J, Davison AJ. The DNA sequence of equine herpesvirus. 2. J Mol Biol 1995; 249:520-8.
71. Tiong SYK, Nash D. The adenosine2 gene of Drosophila melanogaster encodes a formylglycineamide ribotide amidotransferase. Genome 1993;36:924-34.
72. Werner S, Hofschneider PH, Roth WK. Cells derived from sporadic and AlDS-related Kaposi's sarcoma reveal identical cytochemical and molecular properties in vitro. Int J Cancer 1989:43:1137-44.
73. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet 1995:364:799-802.